Prevention & Chronic Conditions

Category icon
ACC 2021 Discussion: The ISCHEMIA Trial

Gregg W Stone, Harriette Van Spall

Category icon
Lifetime management of TAVI patients

Mohamed Abdel-Wahab, Ole De Backer, Raj Makkar et al

Category icon
Coronary CT Angiography-derived FFR

Lavanya Cherukuri, Divya Birudaraju, Matthew J Budoff,

Category icon
The Science of Ultrasound Renal Denervation

Philipp Lurz, Michael Joner, Felix Mahfoud et al

Category icon
Pregnancy in Women with Congenital Heart Disease

Catherine R Weinberg, Amier Ahmad, Boyangzi Li, et al

Category icon
Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

Deepak Bhatt, Anna Meta Dyrvig Kristensen, Manan Pareek, et al

Category icon
Early Management of Hypertension

Deborah L Nadler, Athena Poppas,

Category icon
HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick, Pratik Sandesara, Arshed A Quyyumi, et al

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Related Articles

Articles

Article icon
Major Cardiovascular Advances: Highlights from the 2019 American College…

Hisham A Badreldin, Khalid bin Saleh, Majed Al-Yami,

Published:

Citation: US Cardiology Review 2019;13(2):105–9.

Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

Deepak Bhatt, Anna Meta Dyrvig Kristensen, Manan Pareek,

Published:

Citation: US Cardiology Review 2019;13(2):83–7.

Early Management of Hypertension

Deborah L Nadler, Athena Poppas,

Published:

Citation: US Cardiology Review 2019;13(1):58–60

HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick, Pratik Sandesara, Arshed A Quyyumi,

Published:

Citation: US Cardiology Review 2019;13(1):49–53